Role of Ca2+/calmodulin-dependent protein kinase (CaMK) in excitation-contraction coupling in the heart
- PMID: 17157285
- DOI: 10.1016/j.cardiores.2006.11.005
Role of Ca2+/calmodulin-dependent protein kinase (CaMK) in excitation-contraction coupling in the heart
Abstract
Calcium (Ca(2+)) is the central second messenger in the translation of electrical signals into mechanical activity of the heart. This highly coordinated process, termed excitation-contraction coupling or ECC, is based on Ca(2+)-induced Ca(2+) release from the sarcoplasmic reticulum (SR). In recent years it has become increasingly clear that several Ca(2+)-dependent proteins contribute to the fine tuning of ECC. One of these is the Ca(2+)/calmodulin-dependent protein kinase (CaMK) of which CaMKII is the predominant cardiac isoform. During ECC CaMKII phosphorylates several Ca(2+) handling proteins with multiple functional consequences. CaMKII may also be co-localized to distinct target proteins. CaMKII expression as well as activity are reported to be increased in heart failure and CaMKII overexpression can exert distinct and novel effects on ECC in the heart and in isolated myocytes of animals. In the present review we summarize important aspects of the role of CaMKII in ECC with an emphasis on recent novel findings.
Similar articles
-
Ca2+/calmodulin-dependent protein kinase modulates cardiac ryanodine receptor phosphorylation and sarcoplasmic reticulum Ca2+ leak in heart failure.Circ Res. 2005 Dec 9;97(12):1314-22. doi: 10.1161/01.RES.0000194329.41863.89. Epub 2005 Nov 3. Circ Res. 2005. PMID: 16269653
-
Increased sarcoplasmic reticulum calcium leak but unaltered contractility by acute CaMKII overexpression in isolated rabbit cardiac myocytes.Circ Res. 2006 Feb 3;98(2):235-44. doi: 10.1161/01.RES.0000200739.90811.9f. Epub 2005 Dec 22. Circ Res. 2006. PMID: 16373600
-
Ca2+/calmodulin-dependent protein kinase: a key component in the contractile recovery from acidosis.Cardiovasc Res. 2007 Mar 1;73(4):648-56. doi: 10.1016/j.cardiores.2006.12.002. Epub 2006 Dec 15. Cardiovasc Res. 2007. PMID: 17222810 Review.
-
CaMKII inhibition protects against necrosis and apoptosis in irreversible ischemia-reperfusion injury.Cardiovasc Res. 2007 Mar 1;73(4):689-98. doi: 10.1016/j.cardiores.2006.12.003. Epub 2006 Dec 15. Cardiovasc Res. 2007. PMID: 17217936
-
Modulation of cardiac Na(+) and Ca(2+) currents by CaM and CaMKII.J Cardiovasc Electrophysiol. 2006 May;17 Suppl 1:S26-S33. doi: 10.1111/j.1540-8167.2006.00382.x. J Cardiovasc Electrophysiol. 2006. PMID: 16686679 Review.
Cited by
-
Atherogenic L5 LDL induces cardiomyocyte apoptosis and inhibits KATP channels through CaMKII activation.Lipids Health Dis. 2020 Aug 21;19(1):189. doi: 10.1186/s12944-020-01368-7. Lipids Health Dis. 2020. PMID: 32825832 Free PMC article.
-
Trans-cinnamaldehyde protects against phenylephrine-induced cardiomyocyte hypertrophy through the CaMKII/ERK pathway.BMC Complement Med Ther. 2022 Apr 25;22(1):115. doi: 10.1186/s12906-022-03594-1. BMC Complement Med Ther. 2022. PMID: 35468773 Free PMC article.
-
Ca/calmodulin kinase II differentially modulates potassium currents.Circ Arrhythm Electrophysiol. 2009 Jun;2(3):285-94. doi: 10.1161/CIRCEP.108.842799. Epub 2009 Apr 17. Circ Arrhythm Electrophysiol. 2009. PMID: 19808479 Free PMC article.
-
AKAP18δ Anchors and Regulates CaMKII Activity at Phospholamban-SERCA2 and RYR.Circ Res. 2022 Jan 7;130(1):27-44. doi: 10.1161/CIRCRESAHA.120.317976. Epub 2021 Nov 24. Circ Res. 2022. PMID: 34814703 Free PMC article.
-
Clinical Evidence and Proposed Mechanisms of Sodium-Glucose Cotransporter 2 Inhibitors in Heart Failure with Preserved Ejection Fraction: A Class Effect?Card Fail Rev. 2022 Jun 29;8:e23. doi: 10.15420/cfr.2022.11. eCollection 2022 Jan. Card Fail Rev. 2022. PMID: 35846984 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous
